loadpatents
Patent applications and USPTO patent grants for Livingston; Philip O..The latest application filed is for "polyvalent conjugate vaccine for cancer".
Patent | Date |
---|---|
Polyvalent conjugate vaccine for cancer Grant 9,572,875 - Livingston , et al. February 21, 2 | 2017-02-21 |
Multivalent glycopeptide constructs and uses thereof Grant 9,493,580 - Danishefsky , et al. November 15, 2 | 2016-11-15 |
Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof Grant 9,464,116 - Danishefsky , et al. October 11, 2 | 2016-10-11 |
Polyvalent Conjugate Vaccine For Cancer App 20160250306 - Livingston; Philip O. ;   et al. | 2016-09-01 |
Polyvalent conjugate vaccine for cancer Grant 9,149,516 - Livingston , et al. October 6, 2 | 2015-10-06 |
Potentiating Antibody-induced Complement-mediated Cytotoxicity Via Pi3k Inhibition App 20150023954 - Wu; Xiaohong ;   et al. | 2015-01-22 |
Novel Glycoconjugates, Glycoamino Acids, Intermediates Thereto, And Uses Thereof App 20140271817 - Danishefsky; Samuel J. ;   et al. | 2014-09-18 |
Polyvalent Conjugate Vaccine For Cancer App 20140037673 - Livingston; Philip O. ;   et al. | 2014-02-06 |
Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof Grant 8,623,378 - Danishefsky , et al. January 7, 2 | 2014-01-07 |
Polyvalent conjugate vaccine for cancer Grant 8,540,964 - Livingston , et al. September 24, 2 | 2013-09-24 |
Multivalent Glycopeptide Constructs And Uses Thereof App 20130095173 - Danishefsky; Samuel J. ;   et al. | 2013-04-18 |
Polyvalent Conjugate Vaccine For Cancer App 20120263749 - Livingston; Philip O. ;   et al. | 2012-10-18 |
Polyvalent conjugate vaccine for cancer Grant 8,092,780 - Livingston , et al. January 10, 2 | 2012-01-10 |
Novel Glycoconjugates, Glycoamino Acids, Intermediates Thereto, And Uses Thereof App 20110206757 - Danishefsky; Samuel J. ;   et al. | 2011-08-25 |
Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof Grant 7,879,335 - Danishefsky , et al. February 1, 2 | 2011-02-01 |
Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof Grant 7,854,934 - Danishefsky , et al. December 21, 2 | 2010-12-21 |
Glycopeptide conjugates and uses thereof Grant 7,550,146 - Danishefsky , et al. June 23, 2 | 2009-06-23 |
Polyvalent Conjugate Vaccine for Cancer App 20090060938 - Livingston; Philip O. ;   et al. | 2009-03-05 |
Polyvalent conjugate vaccine for cancer Grant 7,479,266 - Livingston , et al. January 20, 2 | 2009-01-20 |
Optimal Polyvalent Vaccine for Cancer App 20080241195 - Livingston; Philip O. ;   et al. | 2008-10-02 |
.alpha.-O-linked glycoconjugates, methods of preparation and uses thereof Grant 7,160,856 - Danishefsky , et al. January 9, 2 | 2007-01-09 |
Optimal polyvalent vaccine for cancer App 20060035267 - Livingston; Philip O. ;   et al. | 2006-02-16 |
Glycopeptide conjugates and uses thereof App 20050222398 - Danishefsky, Samuel J. ;   et al. | 2005-10-06 |
Polyvalent conjugate vaccine for cancer App 20040151733 - Livingston, Philip O. ;   et al. | 2004-08-05 |
Trimeric antigenic O-linked glycopeptide conjugates, methods of preparation and uses thereof App 20040102607 - Danishefsky, Samuel J. ;   et al. | 2004-05-27 |
.alpha.-O-linked glycoconjugates, methods of preparation and uses thereof Grant 6,660,714 - Danishefsky , et al. December 9, 2 | 2003-12-09 |
Fucosyl gm1-klh conjugate vaccine against small cell lung cancer App 20030171261 - Livingston, Philip O ;   et al. | 2003-09-11 |
Novel glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof App 20030153492 - Danishefsky, Samuel J. ;   et al. | 2003-08-14 |
Alpha-o-linked glycoconjugates, methods of preparation and uses thereof App 20030083235 - Danishefsky, Samuel J. ;   et al. | 2003-05-01 |
Synthesis of glycoconjugates of the globo-H epitope and uses thereof Grant 6,544,952 - Danishefsky , et al. April 8, 2 | 2003-04-08 |
Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof Grant 6,090,789 - Danishefsky , et al. July 18, 2 | 2000-07-18 |
Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof Grant 5,708,163 - Danishefsky , et al. January 13, 1 | 1998-01-13 |
Vaccine for stimulating or enhancing production of antibodies against 9-O-acetyl GD3 Grant 5,102,663 - Livingston , et al. April 7, 1 | 1992-04-07 |
Human monoclonal antibodies to cell surface antigens of melanoma Grant 5,006,470 - Yamaguchi , et al. April 9, 1 | 1991-04-09 |
Melanoma tumor antigen and autologous antibody Grant 4,562,160 - Real , et al. December 31, 1 | 1985-12-31 |
NCAGE Code | 459F0 | LIVINGSTON PHILIP O |
CAGE Code | 459F0 | LIVINGSTON, PHILIP O |
SEC | 0001612050 | Livingston Philip O. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.